Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Role of sodium-glucose cotransporter 2 inhibition to mitigate diabetic kidney
disease risk in type 1 diabetes.
Authors
van Raalte DH, Bjornstad P
Submitted By
Petter Bjornstad on 2/12/2020
Status
Published
Journal
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Year
2020
Date Published
1/1/2020
Volume : Pages
35 : i24 - i32
PubMed Reference
32003832
Abstract
Diabetic kidney disease (DKD) is a common complication of type 1 diabetes (T1D)
and a major risk factor for premature death from cardiovascular disease (CVD).
Current treatments, such as control of hyperglycaemia and hypertension, are
beneficial, but only partially protect against DKD. Finding new, safe and
effective therapies to halt nephropathy progression has proven to be
challenging. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have
demonstrated, in addition to glycaemic lowering, impressive protection against
DKD and CVD progression in people with type 2 diabetes. Although these
beneficial cardiorenal effects may also apply to people with T1D, supporting
data are lacking. Furthermore, the increased rates of euglycaemic diabetic
ketoacidosis may limit the use of this class in people with T1D. In this review
we highlight the pathophysiology of DKD in T1D and the unmet need that exists.
We further detail the beneficial and adverse effects of SGLT2 inhibitors based
on their mechanism of action. Finally, we balance the effects in people with T1D
and indicate future lines of research.
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!